FDA
label_change
· 2013-05-15
FDA Approved: PULMICORT RESPULES — Supplemental Application (AstraZeneca Pharmaceuticals LP)
Summary
The FDA approved a supplemental application for Pulmicort RespuLes (budesonide) from AstraZeneca, resulting in labeling changes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for PULMICORT RESPULES (BUDESONIDE)